Literature DB >> 9973290

Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26.

H Ikeda1, T Sasaki, T Yoshimoto, M Fukui, T Arinami.   

Abstract

Moyamoya disease is characterized by bilateral stenosis and/or occlusion of the terminal portion of the internal carotid artery. Moyamoya disease is prevalent among patients <10 years of age. Although most cases appear to be sporadic, approximately 10% occur as familial cases. The incidence of familial cases has been increasing because noninvasive diagnostic equipment, such as magnetic-resonance imaging and magnetic-resonance angiography, can detect the disease in almost all affected patients, including asymptomatic patients, during screening studies. In this study, we performed a total genome search to identify the location of a familial moyamoya disease gene in 16 families, assuming an unknown mode of inheritance. A linkage was found between the disease and markers located at 3p24.2-26. A maximum NPL score of 3.46 was obtained with marker D3S3050. This is the first genetic locus found to be involved in the molecular pathogenesis of familial moyamoya disease.

Entities:  

Mesh:

Year:  1999        PMID: 9973290      PMCID: PMC1377762          DOI: 10.1086/302243

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  11 in total

1.  Worldwide distribution of moyamoya disease.

Authors:  Y Goto; Y Yonekawa
Journal:  Neurol Med Chir (Tokyo)       Date:  1992-11       Impact factor: 1.742

2.  The simulation of mendelism.

Authors:  J H EDWARDS
Journal:  Acta Genet Stat Med       Date:  1960

Review 3.  Current state of study on moyamoya disease in Japan.

Authors:  M Fukui
Journal:  Surg Neurol       Date:  1997-02

4.  Increase in elastin gene expression and protein synthesis in arterial smooth muscle cells derived from patients with Moyamoya disease.

Authors:  M Yamamoto; M Aoyagi; S Tajima; H Wachi; N Fukai; Y Matsushima; K Yamamoto
Journal:  Stroke       Date:  1997-09       Impact factor: 7.914

5.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

Authors:  J Suzuki; A Takaku
Journal:  Arch Neurol       Date:  1969-03

6.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.

Authors:  E Lander; L Kruglyak
Journal:  Nat Genet       Date:  1995-11       Impact factor: 38.330

7.  Identification of the von Hippel-Lindau disease tumor suppressor gene.

Authors:  F Latif; K Tory; J Gnarra; M Yao; F M Duh; M L Orcutt; T Stackhouse; I Kuzmin; W Modi; L Geil
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

8.  Cerebral haemorrhage in Moyamoya disease at autopsy.

Authors:  K Oka; M Yamashita; S Sadoshima; K Tanaka
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

9.  Evidence for inter-generational instability in the CAG repeat in the MJD1 gene and for conserved haplotypes at flanking markers amongst Japanese and Caucasian subjects with Machado-Joseph disease.

Authors:  Y Takiyama; S Igarashi; E A Rogaeva; K Endo; E I Rogaev; H Tanaka; R Sherrington; K Sanpei; Y Liang; M Saito
Journal:  Hum Mol Genet       Date:  1995-07       Impact factor: 6.150

10.  A second locus for Marfan syndrome maps to chromosome 3p24.2-p25.

Authors:  G Collod; M C Babron; G Jondeau; M Coulon; J Weissenbach; O Dubourg; J P Bourdarias; C Bonaïti-Pellié; C Junien; C Boileau
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

View more
  57 in total

1.  Comparative analysis of serum proteomes of moyamoya disease and normal controls.

Authors:  Eun-Jeong Koh; Han-Na Kim; Tian-Ze Ma; Ha-Young Choi; Yong-Geun Kwak
Journal:  J Korean Neurosurg Soc       Date:  2010-07-31

Review 2.  [Moyamoya disease].

Authors:  P Papanagiotou; I Q Grunwald; M Politi; C Roth; W Reith
Journal:  Radiologe       Date:  2005-05       Impact factor: 0.635

Review 3.  Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.

Authors:  Jialing Liu; Yongting Wang; Yosuke Akamatsu; Chih Cheng Lee; R Anne Stetler; Michael T Lawton; Guo-Yuan Yang
Journal:  Prog Neurobiol       Date:  2013-11-27       Impact factor: 11.685

4.  P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure.

Authors:  Akio Koizumi; Hatasu Kobayashi; Wanyang Liu; Yukiko Fujii; S T M L D Senevirathna; Shanika Nanayakkara; Hiroko Okuda; Toshiaki Hitomi; Kouji H Harada; Katsunobu Takenaka; Takao Watanabe; Shinichiro Shimbo
Journal:  Environ Health Prev Med       Date:  2012-08-10       Impact factor: 3.674

5.  Moyamoya disease in pregnancy: maintenance of maternal blood pressure.

Authors:  Helen L Barrett; Karin Lust; Narelle Fagermo; Leonie K Callaway; Lee Minuzzo
Journal:  Obstet Med       Date:  2011-12-08

6.  Pediatric and newborn stroke.

Authors:  Sharon Goodman; Steven Pavlakis
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

7.  The roles of methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms in moyamoya disease patients.

Authors:  Young Seok Park; Young Joo Jeon; Hyun Seok Kim; In Bo Han; Joong-Uhn Choi; Dong-Seok Kim; Nam Keun Kim
Journal:  Childs Nerv Syst       Date:  2014-08-07       Impact factor: 1.475

Review 8.  Moyamoya disease: a clinical spectrum, literature review and case series from a tertiary care hospital in Pakistan.

Authors:  Sana Shoukat; Ahmed Itrat; Ather M Taqui; Moazzam Zaidi; Ayeesha K Kamal
Journal:  BMC Neurol       Date:  2009-04-15       Impact factor: 2.474

9.  Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS.

Authors:  Yoshio Araki; Kazuhiro Yoshikawa; Sho Okamoto; Masaki Sumitomo; Mikio Maruwaka; Toshihiko Wakabayashi
Journal:  BMC Neurol       Date:  2010-11-08       Impact factor: 2.474

10.  Pituitary stalk duplication in association with moya moya disease and bilateral morning glory disc anomaly - broadening the clinical spectrum of midline defects.

Authors:  T Loddenkemper; N R Friedman; P M Ruggieri; A Marcotty; J Sears; E I Traboulsi
Journal:  J Neurol       Date:  2008-03-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.